Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Methodological Open-Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarisation and QT Interval At Fixed Heart Rate Under Autonomic Blockade

NCT00174512 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00174512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Methodological Open-Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarisation and QT Interval At Fixed Heart Rate Under Autonomic Blockade
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2005
Completion date
June 30, 2006
Enrollment
36
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

patients with pace makers but no evidence of ischemic heart disease